Lowenstein Sandler represented Corbus Pharmaceuticals Holdings, Inc. in the transaction.Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a precision oncology company with a diversified portfolio, announced the closing…
Corbus Pharmaceuticals’ $94.5 Million Shares Public Offering
![](https://globallegalchronicle.com/wp-content/uploads/2024/02/corbus-pharmaceuticals-94-5-million-shares-public-offering_65c5cce0204fb.jpeg)